News

VTC Seed Fund Adds SWARM Engineering to Portfolio

SWARM Engineering, Inc, the next generation of cognitive software for the food supply chain, announced it has closed funding for a $2.7 million seed round.

SWARM Engineering is a Software-as-a-Service (SaaS) platform specifically for the food supply chain, rapidly solving complex problems such as supply & demand forecasting, optimizing inbound and outbound logistics, or maximizing yield in controlled environment agriculture. SWARM is a ‘no-code’ solution, so end users do not need data science expertise, knowledge of machine learning, or a degree in math to use the software. Business users simply define their problem, and SWARM matches their definition with a curated library of algorithms (which can be added to by customers or 3rd parties) to rapidly deliver a solution via the cloud.

S2G Ventures, a Chicago-based investment firm focused on food and agriculture, led the seed round, which included participation from Serra Ventures via their new AgTech fund, Harvard Business School Alumni, Wells Street Capital, VTC Seed Fund, and Rinvest. Angel investor and former CEO of Bunge, Soren Schroder, also participated in the round. The capital will support continued technological innovation and team growth, to support an expanding list of customers, ranging from growers through to dedicated logistics firms.

SWARM are anticipating continued growth in ag-data, combined with an ongoing scarcity of data scientists, especially those with agricultural expertise. They aim to simplify the use of AI and advanced Machine Learning in the food supply chain, so that organizations can reap the rewards of the huge advances being made, at affordable price points, using existing team members’ skills and knowledge.

Anthony Howcroft, CEO and founder of SWARM Engineering said, “I’m excited to have the capital to continue SWARM’s exciting journey in solving real-world problems for food supply chain organizations, but I’m even more thrilled to be partnering with investors who are so knowledgeable and committed to this space.”

“SWARM has developed a truly disruptive technology which harnesses AI & ML to drive massive efficiency gains across multiple verticals within the broader food supply chain. Part of what makes SWARM’s approach so revolutionary is that it democratizes AI & ML by making it both useful, and useable for its clients in the ‘real world’.” said James Ramey, Managing Member of the VTC Seed Fund.

Soren Schroeder, former CEO of Bunge a global agribusiness and food company says, “The Ag-Food supply chain is all about optimization and prediction. Often the biggest challenge is to define a problem very precisely. SWARM can help companies – large and small – define and solve very complex problems quickly, using the latest in data technology.”

The global pandemic has highlighted the critical importance of supply chains, and food has frequently made headlines – in many cases, for all the wrong reasons; who can forget seeing dramatic images of milk being poured away because of logistical challenges? “In the next few years, we have a tremendous opportunity to make a step change in efficiency and sustainability in food production and transportation,” says Howcroft, “We need to give the right tools to the people at the heart of the food supply chain to help them deliver this transformation.”

Recent News

09/17/2026

From Lab to Three Continents: Agrospheres and FMC Corporation Advance Bioinsecticide Pipeline into Global Field Trials

AgroSpheres, a biotechnology company pioneering breakthroughs in sustainable crop protection and FMC Corporation (NYSE: FMC), a global leader in agricultural sciences, today announced a significant advancement in its ongoing collaboration. Two proprietary RNA-based biomolecule candidates from AgroSpheres’ pipeline are now entering global field trial development, marking the transition from discovery into real-world testing across three

09/15/2026

Jazz Pharmaceuticals Completes Acquisition of Actio Biosciences

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (“Jazz” or the “Company”) today announced the successful completion of its acquisition of privately-held Actio Biosciences, Inc. (“Actio”) for $820 million upfront. Actio is now a wholly-owned subsidiary of Jazz. “ABS-1230 holds the promise of being a transformative, first-in-class therapy for individuals living with KCNT1-related epilepsy,” said Renee Gala, president and

09/14/2026

BRAINBox Solutions Announces Agreement with Prolight Diagnostics for Commercial Supply of Pyros® Devices for Delivery of BRAINBox Concussion Diagnostics/Prognostics at Point-of-Care

BRAINBox Solutions announced it has entered into an agreement with Prolight Diagnostics to supply its Psyros® instruments and cartridges for use in point-of-care (PoC) delivery of BRAINBox’s TBI diagnostic/prognostic tests for concussion (also known as mTBI or Acute Traumatic Encephalopathy). “This agreement is an important step towards commercialization of our solutions and reflects the successful